|
QSER1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.889190E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.369000E-01 |
| Normal-vs-Stage2 |
3.452000E-01 |
| Normal-vs-Stage3 |
3.035500E-02 |
| Normal-vs-Stage4 |
1.595780E-01 |
| Stage1-vs-Stage2 |
5.524600E-01 |
| Stage1-vs-Stage3 |
3.226200E-02 |
| Stage1-vs-Stage4 |
2.399000E-01 |
| Stage2-vs-Stage3 |
4.484600E-01 |
| Stage2-vs-Stage4 |
8.069200E-01 |
| Stage3-vs-Stage4 |
5.898800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.454800E-01 |
| Normal-vs-AfricanAmerican |
1.076100E-02 |
| Normal-vs-Asian |
3.525200E-01 |
| Caucasian-vs-AfricanAmerican |
4.618000E-02 |
| Caucasian-vs-Asian |
2.153800E-01 |
| AfricanAmerican-vs-Asian |
3.102400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.815250E-01 |
| Normal-vs-Female |
2.685000E-01 |
| Male-vs-Female |
6.958600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.518800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.283800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.157010E-01 |
| Normal-vs-Age(81-100Yrs) |
1.380250E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.043000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.021400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.476600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.640400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.187800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.421430E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.620800E-01 |
| Normal-vs-Grade 2 |
8.395200E-01 |
| Normal-vs-Grade 3 |
1.730010E-02 |
| Normal-vs-Grade 4 |
5.286400E-02 |
| Grade 1-vs-Grade 2 |
5.652000E-01 |
| Grade 1-vs-Grade 3 |
6.121600E-02 |
| Grade 1-vs-Grade 4 |
1.478020E-01 |
| Grade 2-vs-Grade 3 |
8.242400E-03 |
| Grade 2-vs-Grade 4 |
4.131600E-02 |
| Grade 3-vs-Grade 4 |
6.790200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.928000E-01 |
| Normal-vs-ccB subtype |
1.248560E-01 |
| ccA subtype-vs-ccB subtype |
2.898500E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.843600E-01 |
| Normal-vs-N1 |
8.287200E-01 |
| N0-vs-N1 |
7.814800E-01 |
|
|
